ファグのQbeta virionに含まれるタンパク質抗生物質:溶解標的の多様性
T G Bernhardt1, I N Wang, D K Struck
1Department of Biochemistry and Biophysics, Texas A&M University, 2128 TAMU, College Station, TX 77843-2128, USA..
Science (New York, N.Y.)
|June 26, 2001
まとめ
Qベータファグタンパク質A(2) は,Mura酵素を阻害することによって,細菌の細胞壁前駆体合成を停止します. この発見は,phiX174.4のような他のファグとは異なる新しい宿主溶解機構を明らかにしています.
科学分野:
- 微生物学 微生物学とは
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- バクテリア宿主の溶解は,バクテリオファージの複製に不可欠です.
- 細胞壁のバイオシンセシスは,細菌において保存され,不可欠な経路である.
- RNAファグQbetaは,宿主溶解のためにそのカプシドタンパク質A(2) を利用する.
研究 の 目的:
- Qベータファグタンパク質A(2) が宿主細胞溶解を誘導する分子機構を解明する.
- Aによって抑制された特定の細菌の標的酵素を特定するために.
- Qベータファグの溶解戦略を,他の既知のファグと比較する.
主な方法:
- ミュレイン前駆体合成に対するA(2) の影響を評価するためのインビボ試験.
- 浄化された野生型および変異したMur.A.を使用した酵素阻害アッセイ.
- MurA.のA(2) 耐性突然変異をマッピングするための遺伝分析.
主要な成果:
- タンパク質A(2) は,ムレイン生物合成の重要な酵素であるMuraAを阻害し,先駆体合成をin vivoで阻害する.
- 基板結合部位の近くのMuraAで,A(2) 耐性を与える変異が特定されました.
- 浄化されたQベータウイルスは,野生型のMurAの抑制を示したが,変異酵素の抑制は in vitro では示されなかった.
結論:
- Qベータファグタンパク質A(2) は,バクテリアの細胞壁合成を妨害するためにMurAを標的にし,新しい溶解機構を表しています.
- このメカニズムは,phiX174.4のような小さなDNAファグで用いられる溶解戦略とは異なる.
- この発見は,保存された細胞壁の生物合成経路内で宿主解離を達成するためにファグが使用する多様な酵素標的を強調しています.
関連する概念動画
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
01:22Bacterial Cell Wall
The bacterial cell wall is an essential structural component that encases the plasma membrane, preserving cellular integrity, determining shape, and protecting against osmotic stress. This rigid yet flexible structure primarily comprises peptidoglycan, a polymer that forms a mesh-like matrix conferring mechanical strength and flexibility.Peptidoglycan Composition and StructurePeptidoglycan, the core of the bacterial cell wall, comprises alternating units of N-acetylglucosamine (NAG) and...
01:20Viral Replication: Lytic Cycle
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
01:16Viral Replication: Lysogenic Cycle
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects its...
01:12Bacterial Toxins
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
01:28Regulation of Bacterial Virulence
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...